Regorafenib plus sintilimab as a salvage treatment for microsatellite stable metastatic colorectal cancer: a single-arm, open-label, phase II clinical trial

Rui Liu

Zhi Ji

Xia Wang

Lila Zhu

Jiaqi Xin

Lijun Ma

Jiayu Zhang

Shaohua Ge

Le Zhang

Yuchong Yang

Yusuf Hamied Department of Chemistry

Tao Ning

Ming Bai

Jingjing Duan

Sphingolipid Metabolism and Aging, Human Aging Research Institute (HARI) and School of Life Science, Nanchang University, Jiangxi Key Laboratory of Aging and Disease, Nanchang, Jiangxi, China.

Feixue Wang

Yansha Sun

Hongli Li

Key Laboratory of Genetic Evolution and Animal Models of the Chinese Academy of Sciences, Key Laboratory of Animal Models and Human Disease Mechanisms of Yunnan Province, and Kunming Institute of Zoology and Chinese University of Hong Kong Joint Laboratory of Bioresources and Molecular Research in Common Diseases, Kunming Institute of Zoology, Chinese Academy of Sciences

Ting Deng

Shanghai Key Laboratory of Green Chemistry and Chemical Processes, State Key Laboratory of Petroleum Molecular & Process Engineering, School of Chemistry and Molecular Engineering

Yi Ba

Jihui Hao